MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept Total Current Liabilities 2011-2026 | VERO
Annual Total Current Liabilities Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.3 M | 31.2 M | 39.6 M | 34.7 M | 32.5 M | 48.2 M | 9.38 M | 14 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 48.2 M | 9.38 M | 30 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.19 | 2.34 % | $ 3.42 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 10.76 | 3.26 % | $ 1.45 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.16 | 6.39 % | $ 881 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 12.79 | 1.51 % | $ 1.92 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.41 | 0.36 % | $ 604 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 71.27 | 2.13 % | $ 106 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.62 | -2.11 % | $ 1.14 B | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.69 | 6.85 % | $ 37.6 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.16 | 4.95 % | $ 155 M |  France |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
82.1 M | $ 65.06 | 2.49 % | $ 1.93 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
10.4 M | $ 11.2 | 1.5 % | $ 303 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.44 | 0.11 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.19 | - | $ 1.33 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 62.11 | 1.1 % | $ 3.39 B |  Britain |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 13.67 | 1.79 % | $ 884 M | Israel |
 |
Abbott Laboratories
ABT
|
16.5 B | $ 111.4 | 1.32 % | $ 194 B | USA |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.34 | 0.77 % | $ 21.6 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.87 | 0.56 % | $ 354 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 266.93 | 2.18 % | $ 7.53 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.28 | 3.0 % | $ 715 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 33.06 | 0.68 % | $ 1.52 B | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 177.13 | 4.53 % | $ 13.3 B | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 33.64 | 2.69 % | $ 5.01 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.83 | 4.36 % | $ 157 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.3 | 1.08 % | $ 406 M | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 86.69 | 3.12 % | $ 3.01 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |